Cornelius Arjan Van Oeveren

Title: The Innovative Contributions of Cornelius Arjan Van Oeveren

Introduction: Cornelius Arjan Van Oeveren is a notable inventor based in San Diego, CA, whose work has significantly impacted the field of medical research. With a focus on the granulocyte colony-stimulating factor receptor, he has contributed valuable insights and methods that possess the potential to transform treatments for various disorders.

Latest Patents: Van Oeveren holds one patent entitled "Methods and compositions associated with the granulocyte colony-stimulating factor receptor." This innovative patent includes embodiments that cover compositions and methods for identifying compounds that modulate the activity of the granulocyte colony-stimulating factor receptor (GCFR). Additionally, the patent outlines potential uses of these compounds in treating hematopoietic and neurological disorders.

Career Highlights: Cornelius Arjan Van Oeveren is currently employed at Ligand Pharmaceuticals, Inc., where he continues to advance his research and apply his inventions in practical applications within the pharmaceutical industry. His expertise and dedication to innovation make him a valuable asset to his company and the broader medical research community.

Collaborations: Throughout his career, Van Oeveren has collaborated with many talented individuals, including his coworkers Lin Zhi and Andrew Richard Hudson. These collaborations enhance the research process and foster innovative ideas, ultimately leading to advancements in their respective fields.

Conclusion: Cornelius Arjan Van Oeveren exemplifies the spirit of innovation in the medical and pharmaceutical industries. His contributions to understanding and utilizing the granulocyte colony-stimulating factor receptor pave the way for new therapies and improved patient outcomes. As he continues his work at Ligand Pharmaceuticals, the potential for further impactful inventions remains promising.